Lixte Biotechnology Holdings, Inc. Warrants

$0.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.101 (-11.09%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can watch LIXTW and buy or sell other stocks, options, and ETFs commission-free!

About LIXTW

Lixte Biotechnology Holdings, Inc. engages in the development of drugs for cancer treatment. The firm uses biomarker technology to identify enzyme targets associated with serious common diseases and designs novel compounds to attack those targets. Its product pipeline is primarily focused on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers, and encompasses two major categories of compounds at various stages of pre-clinical and clinical development that the Company believes have broad therapeutic potential not only for cancer but also for other debilitating and life-threatening diseases. The company was founded by John S. Kovach and Robert B. Royds on August 9, 2005 and is headquartered in East Setauket, NY. The listed name for LIXTW is Lixte Biotechnology Holdings, Inc. Warrants.

CEO
John S. Kovach, MD
Employees
—
Headquarters
East Setauket, New York
Founded
2005
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
3.41K
High Today
$0.81
Low Today
$0.81
Open Price
$0.81
Volume
158.00
52 Week High
$6.77
52 Week Low
$0.65

Collections

You May Also Like

JHME
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure